Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Iavarone

Showing results (21-30 of 145) with videos related to

Pageof 15
Sort By:
World Journal of Hepatology|August 25, 2015
Second line systemic therapies for hepatocellular carcinoma: Reasons for the failureMarcello Maida, Massimo Iavarone, Maurizio Raineri, et al.
Thyroid : Official Journal of the American Thyroid Association|September 10, 2010
Sorafenib-induced destructive thyroiditisMassimo Iavarone, Michela Perrino, Mauro Viganò, et al.
Hepatology (Baltimore, Md.)|July 3, 2023
Indolent cancer and pattern of progression: Two missing parameters in trial design for hepatologyMassimo Iavarone, Jean-Charles Nault, Giuseppe Cabibbo, et al.
AIDS (London, England)|July 13, 2018
Severe cholestatic hepatitis related to abacavir/lamivudine/dolutegravir antiretroviral treatment in a HIV-1 infected subjectRoberto Rossotti, Marco Maggioni, Marco Merli, et al.
Gastroenterology|November 7, 2007
Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patientsPietro Lampertico, Mauro Viganò, Elena Manenti, et al.
Hepatology (Baltimore, Md.)|December 1, 2005
Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudinePietro Lampertico, Mauro Viganò, Elena Manenti, et al.
European Journal of Clinical Pharmacology|April 19, 2018
High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosisElena Arsiè, Stefania Piconi, Massimo Iavarone, et al.
United European Gastroenterology Journal|July 13, 2016
Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenibMassimo Iavarone, Massimo Primignani, Sara Vavassori, et al.
Hepatology (Baltimore, Md.)|March 16, 2017
Uncommon extrahepatic metastases from hepatocellular carcinomaLuigia Florimonte, Massimo Iavarone, Massimo Castellani, et al.
Journal of Viral Hepatitis|June 10, 2019
TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antiviralsElisabetta Degasperi, Enrico Galmozzi, Floriana Facchetti, et al.
Pageof 15

Showing results (21-30 of 145) with videos related to

Sort By:
Pageof 15
World Journal of Hepatology|August 25, 2015
Second line systemic therapies for hepatocellular carcinoma: Reasons for the failureMarcello Maida, Massimo Iavarone, Maurizio Raineri, et al.
Thyroid : Official Journal of the American Thyroid Association|September 10, 2010
Sorafenib-induced destructive thyroiditisMassimo Iavarone, Michela Perrino, Mauro Viganò, et al.
Hepatology (Baltimore, Md.)|July 3, 2023
Indolent cancer and pattern of progression: Two missing parameters in trial design for hepatologyMassimo Iavarone, Jean-Charles Nault, Giuseppe Cabibbo, et al.
AIDS (London, England)|July 13, 2018
Severe cholestatic hepatitis related to abacavir/lamivudine/dolutegravir antiretroviral treatment in a HIV-1 infected subjectRoberto Rossotti, Marco Maggioni, Marco Merli, et al.
Gastroenterology|November 7, 2007
Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patientsPietro Lampertico, Mauro Viganò, Elena Manenti, et al.
Hepatology (Baltimore, Md.)|December 1, 2005
Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudinePietro Lampertico, Mauro Viganò, Elena Manenti, et al.
European Journal of Clinical Pharmacology|April 19, 2018
High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosisElena Arsiè, Stefania Piconi, Massimo Iavarone, et al.
United European Gastroenterology Journal|July 13, 2016
Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenibMassimo Iavarone, Massimo Primignani, Sara Vavassori, et al.
Hepatology (Baltimore, Md.)|March 16, 2017
Uncommon extrahepatic metastases from hepatocellular carcinomaLuigia Florimonte, Massimo Iavarone, Massimo Castellani, et al.
Journal of Viral Hepatitis|June 10, 2019
TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antiviralsElisabetta Degasperi, Enrico Galmozzi, Floriana Facchetti, et al.
Pageof 15